Polyclonal antibodies for worldwide applications
The scientists at ImmunoReagents have over 30 years of experience in production and purification of polyclonal antibodies. Our antibodies are used by the in vitro diagnostic, pharmaceutical and life science markets worldwide. We provide an extensive line of secondary antibodies developed in chickens, goats, rabbits and donkeys that are cross absorbed to remove unwanted activity to other species antibodies. In addition to our secondary antibodies, we provide affinity purified antibodies to serum proteins, cancer and cardiac markers plus immunoglobulins and bulk serum. Please contact us for more specific information.

We continue to apply our experience and knowledge to custom purification and/or absorption of antibodies. Antibody development services are available to help you develop your antibody in either rabbits or goats. Immunoblots, ELISAs, and IEP testing services are available. Please contact us if you are interested in our custom services.

The Company
ImmunoReagents was incorporated in the State of North Carolina on October 1, 2005, and is privately held and operated by Dr. Ann Black. The Company is located at 840 Main Campus Drive, Suite 3520, Raleigh NC 27606 in the Partners II Building on Centennial Campus at the North Carolina State University Technology Incubator.

ImmunoReagents is dedicated to the production of antibodies used in the in vitro diagnostic and life science markets within cGMP guidelines and QSRs. We provide an extensive line of secondary antibodies developed in chickens, goats, rabbits and donkeys that are cross absorbed to remove unwanted activity to other species antibodies. In addition to our secondary antibodies, we provide affinity purified polyclonal antibodies to serum proteins, cancer and cardiac markers plus immunoglobulins and bulk serum.

Dr. Ann Black
Dr. Black received her PhD. from the Medical College of Georgia in 1985. She has over 25 years of academic and industry experience in immunoassay development and over 20 years experience in developing antibodies used in the life sciences and in vivo diagnostic industries. Dr. Black has firsthand experience in developing and using high affinity antibodies in a variety of immunoassay formats. This experience is why she knows how to meet the antibody requirements of the individual customer. Dr. Black’s professional career includes Baylor College of Medicine, Boehringer Mannheim Diagnostics, Fortron Bio Science (Vice President) and ImmunoReagents (Founder and President).

Mr. Brad Heidinger
Mr. Heidinger brings over 12 years of combined pharmaceutical and biotech experience to ImmunoReagents. Mr. Heidinger has over 10 years experience in manufacturing , quality control and assay development using polyclonal antibodies. He has extensive knowledge in validation studies and cGMP. During his career, he has worked on a variety of R&D projects ranging from cardiac marker discovery to stroke detection. Most notably, Mr. Heidinger co-developed a novel proteomics research tool that is marketed worldwide. Mr. Heidinger’s professional career includes Bayer Health Care, Fortron Bio Science, BioMerieux and ImmunoReagents (Lead Scientist).

Ms. Kay Johnson
Ms. Johnson brings more than twenty years of experience in Business Administration to ImmunoReagents, including over seven years in the biotech field focusing on antibody products. She is the primary person for handling all accounting, administrative, insurance and human resources activities at ImmunoReagents. Ms. Johnson’s professional career includes IBM, Telcosoft, Fortron Bio Science and ImmunoReagents (Business Administration).